Teladoc Health Target of Unusually Large Options Trading (NYSE:TDOC)

Key Points

• Unusually large options trading: Investors bought 28,675 TDOC call options on Friday — a 102% jump versus typical call volume — as the stock traded up about 6.6% to $6.46.
• Mixed fundamentals and analyst stance: Teladoc reported Q1 EPS of -$0.36 (a slight miss) with revenue of $613.9M, set FY2026 guidance of -1.05 to -0.75 EPS, and carries an average analyst rating of Hold with a $7.47 average price target amid several recent downgrades and one upgrade.
• Insider and institutional moves: CEO Charles Divita III sold 27,731 shares at about $5.49 (reducing his stake ~7.06%), while institutions own roughly 76.82% of the company with notable increases from Vanguard and Allianz.

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) saw some unusual options trading on Friday. Stock investors purchased 28,675 call options on the stock. This represents an increase of 102% compared to the typical volume of 14,214 call options.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on TDOC. BMO Capital Markets decreased their price target on Teladoc Health from $8.00 to $5.00 and set a "market perform" rating on the stock in a research note on Thursday, February 26th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Teladoc Health in a research note on Friday, March 27th. Stifel Nicolaus decreased their price target on Teladoc Health from $8.00 to $6.00 and set a "hold" rating on the stock in a research note on Thursday, February 26th. Bank of America raised Teladoc Health from a "neutral" rating to a "buy" rating and set a $7.00 price target on the stock in a research note on Thursday, February 26th. Finally, JPMorgan Chase & Co. decreased their price target on Teladoc Health from $9.00 to $7.00 and set a "neutral" rating on the stock in a research note on Friday, March 13th. Five investment analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Teladoc Health presently has an average rating of "Hold" and an average price target of $7.47.

Insider Transactions at Teladoc Health

In other Teladoc Health news, CEO Charles Divita III sold 27,731 shares of the company's stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $5.49, for a total value of $152,243.19. Following the completion of the sale, the chief executive officer directly owned 364,784 shares in the company, valued at $2,002,664.16. This represents a 7.06% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.70% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Allianz Asset Management GmbH increased its holdings in shares of Teladoc Health by 189.2% in the 3rd quarter. Allianz Asset Management GmbH now owns 1,619,391 shares of the health services provider's stock valued at $12,518,000 after acquiring an additional 1,059,458 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of Teladoc Health by 4.2% in the 3rd quarter. Vanguard Group Inc. now owns 21,910,950 shares of the health services provider's stock valued at $169,372,000 after acquiring an additional 891,732 shares during the last quarter. Jupiter Asset Management Ltd. purchased a new position in shares of Teladoc Health in the 3rd quarter valued at about $7,576,000. Monaco Asset Management SAM increased its holdings in shares of Teladoc Health by 31.3% in the 3rd quarter. Monaco Asset Management SAM now owns 755,000 shares of the health services provider's stock valued at $5,836,000 after acquiring an additional 180,000 shares during the last quarter. Finally, Hussman Strategic Advisors Inc. purchased a new position in shares of Teladoc Health in the 3rd quarter valued at about $1,136,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Trading Up 6.6%

TDOC traded up $0.40 during mid-day trading on Friday, hitting $6.46. 5,655,385 shares of the stock were exchanged, compared to its average volume of 5,964,341. The firm's fifty day moving average is $5.40 and its two-hundred day moving average is $6.46. Teladoc Health has a 1-year low of $4.40 and a 1-year high of $9.77. The company has a current ratio of 2.77, a quick ratio of 2.67 and a debt-to-equity ratio of 0.72. The company has a market cap of $1.17 billion, a PE ratio of -6.64 and a beta of 2.07.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.34) by ($0.02). The company had revenue of $613.85 million during the quarter, compared to analyst estimates of $610.87 million. Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.32%. Teladoc Health's revenue for the quarter was down 2.5% on a year-over-year basis. During the same period in the prior year, the business earned ($0.53) EPS. Teladoc Health has set its FY 2026 guidance at -1.050--0.750 EPS and its Q2 2026 guidance at -0.300--0.200 EPS. Equities analysts forecast that Teladoc Health will post -0.89 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc's service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.